Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022

SELL
$57.72 - $65.01 $1.5 Million - $1.69 Million
-26,068 Closed
0 $0
Q1 2022

Apr 12, 2022

BUY
$57.92 - $72.58 $1.38 Million - $1.73 Million
23,896 Added 1100.18%
26,068 $1.55 Million
Q4 2021

Jan 18, 2022

BUY
$64.88 - $73.64 $140,919 - $159,946
2,172 New
2,172 $158,000
Q2 2021

Jul 16, 2021

SELL
$63.47 - $69.35 $202,342 - $221,087
-3,188 Closed
0 $0
Q1 2021

Apr 09, 2021

SELL
$60.0 - $68.46 $325,200 - $371,053
-5,420 Reduced 62.96%
3,188 $206,000
Q4 2020

Jan 11, 2021

SELL
$56.65 - $64.55 $986,899 - $1.12 Million
-17,421 Reduced 66.93%
8,608 $502,000
Q3 2020

Oct 23, 2020

BUY
$62.1 - $78.08 $1.52 Million - $1.91 Million
24,444 Added 1542.21%
26,029 $1.65 Million
Q2 2020

Jul 13, 2020

BUY
$72.34 - $84.0 $15,553 - $18,060
215 Added 15.69%
1,585 $117,000
Q1 2020

Apr 14, 2020

SELL
$62.63 - $80.22 $254,778 - $326,334
-4,068 Reduced 74.81%
1,370 $102,000
Q4 2019

Jan 31, 2020

BUY
$61.62 - $67.78 $279,754 - $307,721
4,540 Added 505.57%
5,438 $353,000
Q3 2019

Oct 15, 2019

BUY
$62.51 - $69.0 $27,754 - $30,636
444 Added 97.8%
898 $57,000
Q2 2019

Jul 18, 2019

SELL
$61.87 - $69.38 $248,284 - $278,421
-4,013 Reduced 89.84%
454 $31,000
Q1 2019

Apr 11, 2019

BUY
$62.53 - $70.05 $242,803 - $272,004
3,883 Added 664.9%
4,467 $291,000
Q4 2018

Jan 22, 2019

BUY
$60.54 - $79.0 $5,872 - $7,663
97 Added 19.92%
584 $36,000
Q3 2018

Oct 23, 2018

BUY
$71.28 - $78.92 $33,786 - $37,408
474 Added 3646.15%
487 $38,000
Q2 2018

Aug 01, 2018

BUY
$64.88 - $75.68 $843 - $983
13 New
13 $1,000
Q1 2018

May 02, 2018

SELL
$72.84 - $88.8 $6,992 - $8,524
-96 Closed
0 $0
Q4 2017

Feb 07, 2018

BUY
$71.15 - $83.52 $6,830 - $8,017
96
96 $7,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Nu Wave Investment Management, LLC Portfolio

Follow Nu Wave Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nu Wave Investment Management, LLC with notifications on news.